Stem Cell Innovations, Inc., (SCLL.PK) announced today that it has filed a new patent application for the production of pluripotent stem cells from primordial germ cells.
Houston, TX (PRWEB) January 22, 2009 -- Stem Cell Innovations, Inc., (SCLL.PK) announced today that it has filed a new patent application for the production of pluripotent stem cells from primordial germ cells. "We have been working for several years to develop a more effective method for producing stem cells from germ cells," said CEO James H. Kelly, PhD. "This filing was submitted to secure our intellectual property prior to publication in the scientific literature."
The Company has been developing PluriCells™ for use in drug discovery. "This application builds on our already strong IP position in germ cell-derived stem cells and will allow us to expand in new directions," explained Kelly.
About Stem Cell Innovations, Inc.:
SCLL is a cell biology company based in Houston, TX. The Company's ACTIVTox system is a human liver based model for high throughput toxicity testing. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells, have the potential to aid in drug discovery, toxicology, and cell therapy.
Contact Stem Cell Innovations:
Dr. James H. Kelly, +1 281-679-7900
ACTIVTox and PluriCells are Trademarks of Stem Cell Innovations, Inc.
Forward Looking Statement
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward looking statements. Forward-Looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We use words such as "expects", "intends", "believes", "may", "will" and "anticipates" to indicate forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including, but not limited to, those risks and uncertainties detailed in the Company's periodic reports filed with the Securities and Exchange Commission. We caution that these risk factors may not be exhaustive. We operate in a continually changing business environment, and new risk factors emerge from time to time. We cannot predict these new risk factors, nor can we assess the effect, if any, of the new risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ from those expressed or implied by these forward-looking statements.
If any one or more of these expectations and assumptions proves incorrect, actual results will likely differ materially from those contemplated by the forward-looking statements. Even if all of the foregoing assumptions and expectations prove correct, actual results may still differ materially from those expressed in the forward-looking statements as a result of factors we may not anticipate or that may be beyond our control. While we cannot assess the future impact that any of these differences could have on our business, financial condition, results of operations and cash flows or the market price of shares of our common stock, the difference could be significant. We do not undertake to update any forward-looking statements made by us, whether as a result of new information, future events or otherwise. You are cautioned.
Read the full story at http://www.prweb.com/releases/2009/01/prweb1897524.htm.
Copyright©2009 Vocus, Inc.
All rights reserved